Forwarded from The Lancet. Read online: https://www.thelancet.com/rheumatology
Presenting The Lancet Rheumatology, a new specialty journal in the Lancet family. As an exclusively online journal, this monthly title is committed to publishing content relevant to rheumatology specialists worldwide, with a focus on studies that advance clinical practice, challenge the status quo, and advocate change in health policy.
Content will include clinical research (with a focus on clinical trials), expert reviews, and provocative comment and opinion relating to the diagnosis & classification, management, and prevention of rheumatic diseases, including arthritic, musculoskeletal, and connective tissue diseases, as well as disorders of the immune system. The journal will also publish high-quality human translational studies that are supported by robust clinical data, with priority given to studies that identify potential new therapeutic targets, advance efforts toward precision medicine, or have the potential to directly inform future clinical trials. With a strong clinical focus, the journal will provide an independent voice for the rheumatology community and will advocate strongly for the improved lives of patients with rheumatic diseases around the globe.
Please register your interest to receive eAlerts about and from this exciting new journal.
To find out more, please contact email@example.com
Best wishes, Neil
Let's build a future where people are no longer dying for lack of healthcare information - Join HIFA: www.hifa.org
HIFA profile: Neil Pakenham-Walsh is coordinator of the HIFA global health campaign (Healthcare Information For All - www.hifa.org ), a global community with more than 19,000 members in 177 countries, interacting on six global forums in four languages. Twitter: @hifa_org FB: facebook.com/HIFAdotORG firstname.lastname@example.org